Evaluation of a Screening Strategy for Sarcopenia: a Monocentric Prospective Cohort Study
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 15
- 试验地点
- 1
- 主要终点
- Number of patients with sarcopenia
研究概览
简要总结
The main objective of this study is to determine the prevalence of sarcopenia in patients hospitalized in the follow-up care and rehabilitation units of the geriatrics department of the Mulhouse French hospital.
详细描述
Secondary objectives
-
To assess the performance of the SARC-F questionnaire to screen for sarcopenia ;
-
To describe the characteristics of sarcopenic patients hospitalized in each follow-up care and rehabilitation unit (i.e. day hospital, full hospitalization);
-
To identify predictive factors of sarcopenia;
-
To determine, in the subgroup of patients hospitalized in the conventional follow-up care and rehabilitation unit (i.e. full hospitalization), the evolution of sarcopenia between admission and discharge of the following variables :
-
muscle strength,
-
muscle mass,
-
functional ability,
-
dependency.
Conduct of research
After receiving the written consent of the study participant, all of the following tests and questionnaires will be performed :
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient 60 years of age or older
- •Patients hospitalized in the follow-up care and rehabilitation units (i.e. day hospital, full hospitalization) of the geriatrics department of the Mulhouse French hospital
- •Patient who gave consent to participate in the study
- •Affiliated or beneficiary of a social security scheme
排除标准
- •Patient admitted for palliative care
- •Bedridden patient
- •Patient with major neurocognitive disorders preventing impedancemetry or grip test from being performed, or any other medical condition preventing impedancemtery or grip test from being performed
- •Patient under legal protection
- •Patient with an unstable psychiatric disorder
- •Patient under guardianship or curatorship
- •Patient already included in the study during a previous hospitalization
- •Secondary exclusion criteria :
- •For patients hospitalized in the conventional follow-up care and rehabilitation unit (i.e. full hospitalization), impedancemtry or grip test not performed within 7 days of admission.
- •Patients excluded secondarily will not be replaced.
研究组 & 干预措施
Patients hospitalized in the follow-up care and rehabilitation units
干预措施: Screening and diagnostic tests for sarcopenia (Procedure)
结局指标
主要结局
Number of patients with sarcopenia
时间窗: Enrollment
The diagnosis of sarcopenia will be established according to the 2018 criteria of the European Working Group On Sarcopenia in Older People (EWGSOP2) based on the evaluation of muscle strength and muscle mass. Sarcopenia will be defined by an abnormal value measured by a grip test and confirmed by an abnormal value of the ASM/size2 ratio measured by impedancemetry.
次要结局
- Sensitivity, specificity, positive and negative predictive value of the SARC-F questionnaire(Enrollment)
- Characteristics of sarcopenic patients hospitalized in each follow-up care and rehabilitation unit (i.e. day hospital, full hospitalization)(Enrollment)
- Muscle strength(Hospital discharge assessed up to 3 months)
- Muscle mass(Hospital discharge assessed up to 3 months)
- 4-meter walking speed test(Hospital discharge assessed up to 3 months)
- Timed-Up and Go test (TUG)(Hospital discharge assessed up to 3 months)
- ADL (Activities of Daily Living) questionnaire(Hospital discharge assessed up to 3 months)
- IADL (Instrumental Activities of Daily Living) questionnaire(Hospital discharge assessed up to 3 months)